PUBLISHER: Allied Market Research | PRODUCT CODE: 1365579
PUBLISHER: Allied Market Research | PRODUCT CODE: 1365579
"The Fetal monitoring Market is likely to experience a significant growth rate of 6.2% from 2023-2032 owing to increase in demand for fetal monitoring devices from medical devices and supplies sector" - Allied Market Research. According to a new report published by Allied Market Research, titled, "Fetal Monitoring Market," The fetal monitoring market was valued at $3.4 billion in 2022, and is estimated to reach $6.2 billion by 2032, growing at a CAGR of 6.2% from 2023 to 2032. Fetal monitoring is a medical process used to assess and record the physiological changes of a developing fetus during pregnancy and labor. It involves the continuous or periodic monitoring of the fetus's heart rate, as well as the mother's contractions, to evaluate the well-being and health status of the unborn baby.
The fetal monitoring market is driven by a rise in the number of preterm births, post-term pregnancy, and multiple pregnancy. For instance, the World Health Organization estimated that 13.4 million babies were born preterm in 2020 (before 37 completed weeks of gestation). In addition, non-invasive fetal monitoring techniques, such as doppler ultrasound and cardiotocography (CTG), are gaining popularity due to their safety and ease of use. These techniques eliminate the need for invasive procedures, thereby improving patient comfort and satisfaction. The increase in demand for non-invasive monitoring methods contributes to the growth of the fetal monitoring market. Furthermore, advancements in fetal monitoring devices propel the market growth. For instance, STAN monitor from Neoventa Medical and ACUSON S3000 ultrasound system from Siemens AG are few novel technologies for fetal heart monitoring. However, stringent regulatory procedures and high costs associated with these devices are anticipated to restrain market growth. Further, emerging technologies, such as portable and wireless products and untapped emerging economies offer lucrative opportunities for the market players.
The fetal monitoring market is segmented into product, method, portability, application, end user, and region. By product, the market is segregated into ultrasound, electronic fetal monitoring (EFM), and accessories and consumables. The ultrasound segment is further categorized into 2D ultrasound, 3D and 4D ultrasound, and doppler imaging. The electronic fetal monitoring (EFM) segment is further divided into external EFM and internal EFM. On the basis of method, the market is bifurcated into invasive and non-invasive. As per portability, it is classified into portable and non-portable. According to the application, it is divided into intrapartum fetal monitoring and antepartum fetal monitoring. Depending on the end user, the market is categorized into hospitals and maternity hospitals, clinics, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
Major key players that operate in the fetal monitoring market are General Electric Company, MedGyn Products, Inc., EDAN Instrument, Inc., FUJIFILM Holdings Corporation, Koninklijke Philips N.V., Siemens AG, Neoventa Medical AB, Natus Medical Incorporated, Arjo, and Cardinal Health Inc. Key players have adopted business expansion, product launch, and partnership as key developmental strategies to improve the product portfolio of the fetal monitoring market. For instance, in May 2023, Cardinal Health Canada announced the plans to open a new distribution center in the Greater Toronto Area (GTA), expanding its distribution footprint to nine strategic locations to better meet the medical and surgical product demands of the Canadian healthcare system.
Additional benefits you will get with this purchase are:
Possible Customization with this report (with additional cost and timeline talk to the sales executive to know more)